Proteins of the SWI/SNF family disrupt chromatin, hydrolysing ATP in the process. How they do so is still mysterious, but recent studies indicate that they can be targeted to the nuclear infrastructure and to particular genes, where they cooperate with other enzymes to activate or repress transcription.
Enzymes drive biological processes. Enzymatic activity does not occur at random within a cell, but is partitioned into particular nuclear or cytoplasmic compartments. This targeting of enzymes provides an important element of control: a set of enzymes might be colocalized so as to channel a substrate more efficiently along a metabolic pathway, or they might be sequestered in an inaccessible and inactive location. Defining the biological functions of an enzyme requires information, not only about what it does mechanistically, but also about the structural context in which it acts. These goals are now beginning to be achieved for members of the large family of DNAdependent ATPases that are characterized by similarity to the SWI2/SNF2 subunit of the yeast SWI/SNF chromatin remodelling complex [1, 2] . Recent experiments have connected different SWI2/SNF2 family members to actin and the nuclear matrix [3] [4] [5] , as well as to specific gene regulation pathways [6] [7] [8] .
The SWI/SNF complex of the budding yeast Saccharomyces cerevisiae is the prototypical chromatin remodelling machine. It consists of twelve proteins, which together are competent to alter the histone-DNA interactions in nucleosomes in a manner dependent on ATP hydrolysis [9] . Eleven of the SWI/SNF complex subunits have now been characterized, with the latest progress being the identification of two actin-related proteins, Arp7 and Arp9, as functional components [3, 5] . Deletion analysis has shown that the Arp7 and Arp9 genes are essential for correct functioning of the yeast SWI/SNF complex in gene regulation.
The presence of actin-related proteins in the SWI/SNF complex raises several interesting functional possibilities. Actin itself is an ATPase with structural similarity to members of the heat shock protein 70 (Hsp70) family of chaperones. This connection suggests that Arp7 and Arp9 might mediate ATP-dependent conformational changes in large protein complexes, such as the histone octamer [3] . Alternatively, Arp7 and Arp9 might connect SWI/SNF to actin-binding proteins, cytoskeletal processes involving actin or structural components of the nuclear infrastructure [5] .
Mutational analysis of Arp7 and Arp9, however, has suggested that ATP binding and hydrolysis are not important for their function in the SWI/SNF complex. Instead, mutations that affect the function of Arp7 and Arp9 were found to occur at sites where they would be expected to destabilize structural features of the protein, including their actin folds [5] . Moreover, Arp7 and Arp9 show no similarity to those parts of actin that interact with known actin-binding proteins. Thus, neither ATP hydrolysis nor interactions with conventional actin-binding proteins appears to contribute to the functioning of Arp7 and Arp9. Yeast genetics indicates that Arp7 and Arp9 are important, but does not tell us why this should be so. Fortunately, some insight into this has come from work on the homologous complexes in metazoans.
The Drosophila gene Brahma (Brm) encodes a protein highly similar in sequence to SWI2/SNF2. Brahma is required for the developmental control of several of the homeotic genes that define segmental identity in the Drosophila embryo. The Brahma protein is assembled into a large complex that includes several other proteins that are homologous to subunits of the yeast SWI/SNF complex, including two actin-related proteins [10] . The equivalent mammalian complex has a similar subunit composition ( Figure 1 ), in which the protein encoded by Brahma-related gene 1, BRG1, forms a complex with the 'BRG1-associated factors' BAF53 and BAF47 [4] . BAF53 is an actin-related protein and BAF47 is β actin itself [4] .
Mammalian cell lines have been generated that are deficient in BRG1, but that contain all other components of the BRG1 complex. These cells have been used to demonstrate that BRG1 is essential for the recruitment of BAF53 and BAF47 into a functional complex. This association also induces stable interaction of the BRG1 complex with an insoluble nuclear infrastructure containing both chromatin and nuclear matrix. This interaction was found to be promoted by T-cell receptor signalling in lymphocyte cell lines, and by direct exposure of nuclei to phosphatidylinositol 4,5-bis-phosphate (PIP 2 ) in vitro.
There is considerable evidence that T-cell activation alters the abundance and metabolism of phosphoinositol lipids in the nucleus [4] . Phosphoinositols are known regulators of actin-dependent functions, and the BRG1 complex can bind known PIP 2 -responsive actin-binding regulatory proteins. Furthermore, the nucleosome-dependent ATPase activity of the BRG1 complex is inhibited by latrunculin B, an inhibitor of actin polymerization [4] . There are thus strong indications that nuclear PIP 2 and the enzymes of phosphoinositol lipid metabolism are part of a signalling pathway that regulates the activity of the BRG1 complex, acting via BAF53 and BAF47 and their association with nuclear actin-binding proteins and/or the nuclear matrix [4] . The nature and roles of the nuclear actin-binding proteins that interact with the BRG1 complex, and the precise signals that modulate the concentrations of nuclear phosphoinositol lipids, are among the important issues that remain to be resolved [4] .
The recognition that the functioning of the BRG1 complex involves its regulated sequestration within the nuclear infrastructure provides a new and important area for future research, but it does not help directly with our understanding of how the complex works -in particular, how it regulates gene expression by remodelling chromatin at a specific targeted promoter. A general problem in understanding SWI/SNF family proteins has been the lack of proven mechanisms for targeting their activities to known genes. Progress in this direction is being made and a recent study [6] has identified a route by which the BRG1 complex is directed to specific target sites on chromatin that depends on the ligand-responsive glucocorticoid receptor.
The BRG1 complex has been known for a while to facilitate transcriptional activation by the ligand-bound glucocorticoid receptor, but the mechanism of targeting has been obscure. Fryer and Archer [6] found that recruitment of the BRG1 complex to the glucocorticoid receptor in vivo is dependent on the presence of ligand. The physical interaction between the receptor and the BRG1 complex was eliminated by addition of an antiprogestin drug, which also blocked chromatin remodelling and transcriptional activation directed by the glucocorticoid receptor on the target gene, in this case the well-studied long terminal repeat promoter of mouse mammary tumor virus (MMTV).
As the interaction of the glucocorticoid receptor with other coactivators, such as the acetyltransferases p300 and SRC1, was unaffected by the antiprogestin drug, Fryer and Archer [6] concluded that hormone-dependent transcriptional activation requires the BRG1 complex to bind to the glucocorticoid receptor and remodel the local chromatin. Because all earlier work on the BRG1 complex involved the non-targeted disruption of histone-DNA interactions, often with a very large molar excess of BRG1, the new results provide the first hard evidence that the BRG1 complex plays an essential role in the known ability of the glucocorticoid receptor to target chromatin remodelling (Figure 2 ). It is presently unclear whether specific components of the BRG1 complex make direct contact with the glucocorticoid receptor or if the association is indirect.
Additional evidence that SWI/SNF family members can be recruited to particular sites on chromosomes, where they exert their chromatin remodelling functions to regulate gene expression, has come from studies of Drosophila embryogenesis. As well as Brahma itself, a further member of the SWI/SNF family has been found to contribute to segment specification during Drosophila development. This is d-Mi2 [7] , which interacts with Hunchback, product of R222 Current Biology, Vol 9 No 6
Figure 1
Comparison the SWI/SNF complexes from yeast, flies and humans. Subunits that are structurally related are highlighted by the yellow rectangles. Known regulatory targets and activities are indicated. Each column lists the known subunits of a single, well-defined complex. 'Regulatory target' refers to a known SWI/SNF complex partner that is a component of some intracellular signal transduction pathway.
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Current Biology one of the 'gap' class segmentation genes; Hunchback in turn binds directly to the regulatory elements of homeotic genes to repress their transcription. The Xenopus Mi-2 homolog has been shown to be part of a protein complex with histone deacetylase activity [8] , so the repression of homeotic genes might involve histone deacetylation. This evidence implicating a SWI/SNF protein in a gene repression pathway is significant, as a global analysis of gene expression in yeast found that 203 genes are activated and 126 repressed as a result of a swi2 mutation [11] . A limited set of genes are thus either activated or repressed by alterations in the activity of a SWI/SNF protein, strong evidence that targeted chromatin remodelling is involved in both the activation and repression of transcription.
With the discovery that SWI/SNF complexes include subunits related to cytoskeletal proteins, and the elucidation of regulated interactions between these complexes and specific chromatin components, there is hope that these intriguing enzymes will soon be integrated into specific signalling pathways. Genome sequencing has revealed 17 members of the SWI/SNF family in the yeast S. cerevisiae, and 21 in the nematode Caenorhabditis elegans [12] . Many of these proteins will be components of distinct regulatory complexes that might be involved in gene activation or repression or both (depending on the target gene). It is also undoubtedly true that SWI/SNF proteins contribute to chromatin and chromosomal dynamics associated with the many other nuclear events that use DNA as a template. What the recent papers clearly establish is that the enzymatic activities of SWI/SNF family proteins can be applied in a very precise manner in response to signalling pathways as diverse as those dependent on phosphoinositols, steroid hormones or the developmentally-regulated appearance of a transcriptional repressor. The emerging picture is that the SWI/SNF proteins act in specific architectural contexts within the nuclear infrastructure [4] , at least in some cases as components of specific regulatory complexes that contain sequence-specific DNA-binding proteins and other coactivators [6] or corepressors [7, 8] . The available evidence suggests that when and where SWI/SNF proteins exert their regulatory functions will be determined in large part by their selective localisation within such structures and complexes.
